We observed a significant upregulation of TIPRL, LC3, and CD44 in tissues of hepatocyte-derived liver diseases such as chronic hepatitis, hepatic steatosis, liver cell degeneration, liver tissue degeneration, and inflammation of the porta area, compared with normal tissues. This evidence concerns the gene MAP1LC3A and Hepatic steatosis.